# Zemdri (plazomicin)

NDC: 80735-820
Generic name: Plazomicin
Labeler / Manufacturer: Cipla Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180716

FDA application: NDA210303

## Active ingredients

- PLAZOMICIN: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"80735-820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=80735-820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1243fcd3-de84-428b-901e-d83d65e4d98c